Toggle light / dark theme

AstraZeneca Rises as Key Lung Cancer Drug Scores Another Win

AstraZeneca Plc shares rose after trial data showed Tagrisso slowed disease progression in patients with advanced lung cancer in another win for the pharmaceutical giant’s blockbuster drug.